Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma

Urothelial cancer (UC) is one of the common refractory tumors and chemotherapy is the primary treatment for it. The advent of immune checkpoint inhibitors (ICI) has facilitated the development of treatment strategies for UC patients. To screen out UC patients sensitive to ICI, researchers have propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yueming, Li, Xuechun, Zhou, Rui, Lin, Anqi, Cao, Manming, Lyu, Qingwen, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424112/
https://www.ncbi.nlm.nih.gov/pubmed/34512351
http://dx.doi.org/10.3389/fphar.2021.723066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424112/
https://www.ncbi.nlm.nih.gov/pubmed/34512351
http://dx.doi.org/10.3389/fphar.2021.723066

Ejemplares similares